GenFleet Therapeutics (Shanghai) completed a successful initial public offering on the Hong Kong Stock Exchange, raising approximately $234 million. The company's shares surged over 100% on the first trading day, reflecting strong investor interest in the biotech sector's resurgence in the region. This IPO is part of a broader wave of biotech financings and public market activity in Hong Kong, marking a positive sign for capital availability in Asian biotech markets.